Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Methylergometrine (0.2mg)
Dosage Form : Injection
Packaging Type : Vial
Packaging : 1ml
Price : ₹1/-
Methezen 0.2 Injection contains Methylergometrine (0.2mg), a potent ergot alkaloid used primarily in obstetric care to manage and prevent postpartum hemorrhage (PPH) due to uterine atony. Uterine atony occurs when the uterus fails to contract effectively after childbirth, leading to excessive bleeding. Methylergometrine works by stimulating uterine muscles, helping the uterus contract and reduce blood loss. This medication plays a crucial role in emergency settings where rapid intervention is necessary to prevent life-threatening hemorrhage.
Methezen 0.2 Injection is most commonly administered by healthcare professionals immediately after delivery to control or prevent postpartum bleeding. It helps in stabilizing the mother's condition by promoting the constriction of blood vessels and reducing the volume of bleeding. Methylergometrine is considered a vital part of the standard care in managing obstetric bleeding complications.
In addition to its use in postpartum hemorrhage, Methylergometrine has some off-label uses in controlling bleeding caused by uterine fibroids or other gynecological procedures. However, its use is strictly monitored due to the possibility of serious side effects, especially with prolonged or inappropriate use.
May cause nausea, vomiting, dizziness, headache, increased blood pressure, abdominal cramps, or uterine hypertonia. Serious side effects like seizures or vasoconstriction are rare but possible.
Utilair 0.2 Injection is used for the prevention and treatment of postpartum hemorrhage due to uterine atony, promoting uterine contraction to control bleeding after childbirth.
Should only be used under the supervision of a healthcare professional. Not recommended for patients with hypertension or cardiovascular disease without doctor approval.
Store at room temperature, away from direct light and moisture. Keep the injection out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation